前列腺癌中的BRCA种系突变：未来是个性化的。
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored.
作者信息
Crocetto Felice, Barone Biagio, Caputo Vincenzo Francesco, Fontana Matteo, de Cobelli Ottavio, Ferro Matteo
机构信息
Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.
Division of Urology, European Institute of Oncology, IRCSS, Milan, Via Ripamonti 435, 20141 Milan, Italy.
出版信息
Diagnostics (Basel). 2021 May 19;11(5):908. doi: 10.3390/diagnostics11050908.
Abstract
Prostate cancer (PCa) is the second most common neoplasm in men and the fifth leading cause of death worldwide [...].
摘要
前列腺癌（PCa）是男性中第二常见的肿瘤，也是全球第五大死因[……]。
相似文献
1
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored.
Diagnostics (Basel). 2021 May 19;11(5):908. doi: 10.3390/diagnostics11050908.
2
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
Eur Urol. 2018 Aug;74(2):218-225. doi: 10.1016/j.eururo.2018.01.035. Epub 2018 Feb 10.
3
Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
Eur Urol Oncol. 2020 Jun;3(3):291-297. doi: 10.1016/j.euo.2019.06.010. Epub 2019 Jul 3.
4
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening.
Ann Oncol. 2020 Nov;31(11):1545-1552. doi: 10.1016/j.annonc.2020.06.025. Epub 2020 Sep 18.
5
[Risk-adapted prostate cancer screening-update 2021].
Urologe A. 2021 May;60(5):592-601. doi: 10.1007/s00120-021-01505-9. Epub 2021 Apr 1.
6
Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.
Eur Urol Oncol. 2020 Apr;3(2):224-230. doi: 10.1016/j.euo.2019.12.003. Epub 2020 Jan 14.
7
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Clin Cancer Res. 2010 Apr 1;16(7):2115-21. doi: 10.1158/1078-0432.CCR-09-2871. Epub 2010 Mar 9.
8
Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.
Front Oncol. 2018 Feb 5;8:16. doi: 10.3389/fonc.2018.00016. eCollection 2018.
9
Bringing Prostate Cancer Germline Genetics into Clinical Practice.
J Urol. 2019 Aug;202(2):223-230. doi: 10.1097/JU.0000000000000137. Epub 2019 Jul 8.
10
Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
BMC Cancer. 2018 Mar 22;18(1):315. doi: 10.1186/s12885-018-4229-5.
引用本文的文献
1
From infection to tumor: genetic evidence of viral antibody immune response' role in urologic cancer development.
Discov Oncol. 2025 May 29;16(1):947. doi: 10.1007/s12672-025-02768-w.
2
Clinical Predictors and Risk Factors of Gleason Score Upgrade: A Retrospective Cohort Analysis.
Diagnostics (Basel). 2025 May 14;15(10):1238. doi: 10.3390/diagnostics15101238.
3
Impact of Nerve-Sparing Techniques on Prostate-Specific Antigen Persistence Following Robot-Assisted Radical Prostatectomy: A Multivariable Analysis of Clinical and Pathological Predictors.
Diagnostics (Basel). 2025 Apr 13;15(8):987. doi: 10.3390/diagnostics15080987.
4
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer.
Int J Mol Sci. 2025 Jan 15;26(2):679. doi: 10.3390/ijms26020679.
5
Identification and validation of CDK1 as a promising therapeutic target for Eriocitrin in colorectal cancer: a combined bioinformatics and experimental approach.
BMC Cancer. 2025 Jan 13;25(1):76. doi: 10.1186/s12885-025-13448-x.
6
Construction of a clinically significant prostate cancer risk prediction model based on traditional diagnostic methods.
Front Oncol. 2024 Dec 20;14:1474891. doi: 10.3389/fonc.2024.1474891. eCollection 2024.
7
Colorectal cancer with a germline BRCA1 variant inherited paternally: a case report.
J Pathol Transl Med. 2024 Nov;58(6):341-345. doi: 10.4132/jptm.2024.08.14. Epub 2024 Sep 5.
8
Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.
Eur J Med Res. 2024 Apr 20;29(1):242. doi: 10.1186/s40001-024-01818-3.
9
Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Eur J Med Res. 2023 Jul 17;28(1):239. doi: 10.1186/s40001-023-01207-2.
10
High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients.
BMC Urol. 2023 Jul 4;23(1):112. doi: 10.1186/s12894-023-01285-8.
本文引用的文献
1
Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer.
Diagnostics (Basel). 2021 Feb 19;11(2):345. doi: 10.3390/diagnostics11020345.
2
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.
Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13.
3
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
JAMA Netw Open. 2020 Oct 1;3(10):e2021692. doi: 10.1001/jamanetworkopen.2020.21692.
4
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a or Gene Alteration.
J Clin Oncol. 2020 Nov 10;38(32):3763-3772. doi: 10.1200/JCO.20.01035. Epub 2020 Aug 14.
5
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23.
6
Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.
Diagnostics (Basel). 2020 Apr 30;10(5):269. doi: 10.3390/diagnostics10050269.
7
Olaparib for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med. 2020 May 28;382(22):2091-2102. doi: 10.1056/NEJMoa1911440. Epub 2020 Apr 28.
8
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.
Eur Urol. 2020 Jan;77(1):24-35. doi: 10.1016/j.eururo.2019.08.025. Epub 2019 Sep 6.
9
From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin.
Diagnostics (Basel). 2019 Jul 26;9(3):83. doi: 10.3390/diagnostics9030083.
10
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
JAMA Oncol. 2019 Apr 1;5(4):523-528. doi: 10.1001/jamaoncol.2018.6760.
Zotero 插件